Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Sep 15, 2020; 12(9): 992-1004
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.992
Table 2 Clinicopathological characteristics and survival of 2604 patients with advanced gastric cancer
VariablePatient number, n (%)Survival periodP value
Gender0.619
Male1939 (74.4)34
Female665 (25.6)32
Age (yr)0.705
< 601289 (49.6)34
≥ 601314 (50.4)32
Lymphatic and/or blood vessel invasion< 0.001
Presence442 (17)24
Absence2162 (83)36
Borrmann type< 0.001
I123 (4.7)60
II464 (17.8)45
III1663 (63.9)34
IV354 (13.6)16
Tumor location< 0.001
Upper third301 (11.6)32
Middle third401 (15.4)33
Lower third1355 (52)39
Whole stomach547 (21)22
Tumor size (mm)< 0.001
< 50911 (35)45
≥ 501693 (65)25
Histologic grade< 0.001
Well972 (37.3)40
Poor1632 (62.7)30
pT category< 0.001
T2323 (12.4)60
T3570 (21.9)37
T4a1440 (51.3)30
T4b271 (10.4)18
pN category< 0.001
N0566 (21.7)60
N1466 (17.9)45
N2624 (24)33
N3948 (36.4)18
Surgical approach< 0.001
Proximal gastrectomy234 (9)38
Distal gastrectomy1586 (60.9)39
Total gastrectomy784 (30.1)22
Radical surgery< 0.001
R02125 (81.7)39
R1/R2479 (18.3)13
Combined resection< 0.001
Presence89 (3.4)18
Absence2125 (96.6)34